[PR]まずは試したいあなたに。トライアルサイズも特別価格 >>『PRIME BUY抗体特割キャンペーン(4/21~)

TCL1A Recombinant antibody

TCL1A Uni-rAbTM Recombinant Antibody for WB, IF/ICC, ELISA
Cat No. 85129-5-RR
Clone No.242623A9

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

WB, IF/ICC, ELISA

TCL1, T-cell leukemia/lymphoma protein 1A, Oncogene TCL-1, 242623A9

Formulation:  PBS and Azide
PBS and Azide
PBS Only
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 

-/ -


ご購入について

国内販売は「コスモ・バイオ株式会社」を通じて行っております。お見積り・ご注文はお近くの販売代理店へご連絡ください。


国内在庫・納期について

約2万点のプロテインテック製品をコスモバイオ社物流センター(国内)に在庫しています。国内在庫の有無はコスモバイオ社ホームページの「品番検索」でカタログ番号を検索して確認できます。


保証・サポートについて

テクニカルサポートまたはご購入後1年間の交換/補填対応を承ります。詳細はこちらをご覧ください。


Tested Applications

Positive WB detected inRamos cells
Positive IF/ICC detected inRamos cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:2000-1:10000
Immunofluorescence (IF)/ICCIF/ICC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

85129-5-RR targets TCL1A in WB, IF/ICC, ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Host / Isotype Rabbit / IgG
Class Recombinant
Type Antibody
Immunogen TCL1A fusion protein Ag0786 相同性解析による交差性が予測される生物種
Full Name T-cell leukemia/lymphoma 1A
Calculated molecular weight 13 kDa
Observed molecular weight 15 kDa
GenBank accession numberBC005831
Gene Symbol TCL1A
Gene ID (NCBI) 8115
Conjugate Unconjugated
Form Liquid
Purification MethodProtein A purification
UNIPROT IDP56279
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol , pH 7.3
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

Background Information

TCL1A, also named as TCL1 and p14 TCL1, enhances cell proliferation, stabilizes mitochondrial membrane potential and promotes cell survival. TCL1A immunodetection is an independent marker of adverse outcome that could be used in routine settings for the management of DLCL patients. TCL1A expression is correlated with shorter time to treatment in chronic lymphocytic leukemia cases and shorter lymphoma-specific survival in mantle cell lymphoma series. It is a potential therapeutic target.

Protocols

Product Specific Protocols
WB protocol for TCL1A antibody 85129-5-RRDownload protocol
IF protocol for TCL1A antibody 85129-5-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...